1. Ivacaftor improves rhinologic, psychologic, and sleep‐related quality of life in G551D cystic fibrosis patients. Issue 3 (24th November 2018) Authors: McCormick, Justin; Cho, Do‐Yeon; Lampkin, Brooks; Richman, Joshua; Hathorne, Heather; Rowe, Steven M.; Woodworth, Bradford A. Journal: International forum of allergy & rhinology Issue: Volume 9:Issue 3(2019:Mar.) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9 (September 2019) Authors: Ratjen, Felix; Davis, Stephanie D; Stanojevic, Sanja; Kronmal, Richard A; Hinckley Stukovsky, Karen D; Jorgensen, Neal; Rosenfeld, Margaret; Kerby, Gwen; Kopecky, Carol; Anthony, Meg; Mogayzel, Peter; Walker, Doug; Zeglin, Britany; Hoover, Wynton; Hathorne, Heather; Slaten, Katie; Dorkin, Henry (... Journal: Lancet Issue: Volume 7:Issue 9(2019) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pilot evaluation of ivacaftor for chronic bronchitis. Issue 6 (June 2016) Authors: Solomon, George M; Hathorne, Heather; Liu, Bo; Raju, S Vamsee; Reeves, Ginger; Acosta, Edward P; Dransfield, Mark T; Rowe, Steven M Journal: Lancet Issue: Volume 4:Issue 6(2016) Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗